Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Neurochemistry

• Publication date

  2001-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1471-4159.2001.00046.xPMID 11208906
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease.

  2000cited by this paper
• Protein Disulfide Isomerase in Alzheimer Disease

  2000cited by this paper
• A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.

  2000cited by this paper
• Phosphorylation Sites on Tau Identified by Nanoelectrospray Mass Spectrometry

  2000cited by this paper
• Activation of p38 Kinase Links Tau Phosphorylation, Oxidative Stress, and Cell Cycle‐Related Events in Alzheimer Disease

  2000cited by this paper
• Cyclin' toward dementia

  2000cited by this paper
• p38 Kinase Is Activated in the Alzheimer's Disease Brain

  1999cited by this paper
• MAP kinase pathways.

  1999cited by this paper
• The Jun Kinase 2 Isoform Is Preferentially Required for Epidermal Growth Factor-Induced Transformation of Human A549 Lung Carcinoma Cells

  1999cited by this paper
• RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease

  1999cited by this paper
• Distinct localization of SAPK isoforms in neurons of adult mouse brain implies multiple signaling modes of SAPK pathway.

  1999cited by this paper
• Human c-Jun N-terminal kinase expression and activation in the nervous system.

  1999cited by this paper
• Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation.

  1999cited by this paper
• The role of cell cycle‐mediated events in Alzheimer's disease

  1999cited by this paper
• Neurofilaments in health and disease.

  1998cited by this paper
• The Active Site of ICP47, a Herpes Simplex Virus–encoded Inhibitor of the Major Histocompatibility Complex (MHC)-encoded Peptide Transporter Associated with Antigen Processing (TAP), Maps to the NH2-terminal 35 Residues

  1997cited by this paper
• Stress‐Activated Protein Kinase/c‐Jun N‐Terminal Kinase Phosphorylates τ Protein

  1997cited by this paper
• 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease

  1997cited by this paper
• Regulation and function of the JNK subgroup of MAP kinases.

  1997cited by this paper
• Mitogen-activated protein kinase pathways.

  1997cited by this paper
• Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases

  1997cited by this paper
• A role for JNK/SAPK in proliferation, but not apoptosis, of IL-3-dependent cells.

  1997cited by this paper
• Induction of cyclin D1 by simian virus 40 small tumor antigen.

  1996cited by this paper
• Mitogen-activated protein kinase cascades and regulation of gene expression.

  1996influential reference
• Oxidative damage in Alzheimer's

  1996cited by this paper
• Aberrant Stress-induced Phosphorylation of Perikaryal Neurofilaments*

  1996cited by this paper
• Advanced Maillard reaction end products are associated with Alzheimer disease pathology

  1994cited by this paper
• Immunohistochemical evidence of antioxidant stress in Alzheimer's disease

  1992cited by this paper
• Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease.

  1992cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• Diagnosis of Alzheimer's disease.

  1988cited by this paper
• Diagnosis of Alzheimer's disease.

  1985cited by this paper
• Paired helical filaments from Alzheimer disease patients contain cytoskeletal components.

  1985cited by this paper

• Amyloid-β can activate JNK signalling via WNT5A-ROR2 to reduce synapse formation in Alzheimer's disease

  2025cites this paper
• Alzheimer's Disease and Frontotemporal Dementia: A Review of Pathophysiology and Therapeutic Approaches

  2025cites this paper
• Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery

  2025cites this paper
• JNK Signaling Pathway Activity Alterations in the Rat Hippocampus: Effect of Age, Alzheimer’s Disease-Like Pathology Development, and the JNK Inhibitor IQ-1S

  2025cites this paper
• Glycyrrhizic Acid From Glycyrrhiza uralensis Fish: A Novel Therapeutic Candidate for Alzheimer's Disease Targeting the JNK Signaling Pathway

  2025cites this paper
• Energy deprivation in youth and old age.

  2025cites this paper
• Drug repurposing for neurodegenerative diseases.

  2024cites this paper
• Exploring the Therapeutic Potential of Glycyrrhiza Compounds in Alzheimer's Disease: A Comprehensive Review.

  2024cites this paper
• Unraveling the Complexity of Human Brain: Structure, Function in Healthy and Disease States.

  2024cites this paper
• Comparison of Neurogenesis Promotion Effects between Cinnamoylquinic Acids in Neural Stem Cells from Adult Mice Brains

  2024cites this paper
• JNK3 Overexpression in the Entorhinal Cortex Impacts on the Hippocampus and Induces Cognitive Deficiencies and Tau Misfolding

  2023cites this paper
• Effect of palmitoylethanolamide on degeneration of a human-derived retinal pigment epithelial cell induced by all-trans retinal.

  2023cites this paper
• Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites (Review)

  2023cites this paper
• Arsenic and Tau Phosphorylation: a Mechanistic Review

  2023cites this paper
• Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment

  2023cites this paper
• Leveraging Plasma Membrane Repair Therapeutics for Treating Neurodegenerative Diseases

  2023cites this paper
• JNK Activation Correlates with Cognitive Impairment and Alteration of the Post-Synaptic Element in the 5xFAD AD Mouse Model

  2023cites this paper
• Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease

  2023cites this paper
• Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders

  2023cites this paper
• JNK Activation in Alzheimer’s Disease Is Driven by Amyloid β and Is Associated with Tau Pathology

  2023cites this paper
• Association between insulin and Nrf2 signalling pathway in Alzheimer's disease: A molecular landscape.

  2023cites this paper
• Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin

  2022influential citation
• FOXG1 as a Potential Therapeutic Target for Alzheimer’s Disease with a Particular Focus on Cell Cycle Regulation

  2022cites this paper
• The 28-day repeated arsenic exposure increases tau phosphorylation in the rat brain.

  2022cites this paper
• Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.

  2022cites this paper
• Identifying New Ligands for JNK3 by Fluorescence Thermal Shift Assays and Native Mass Spectrometry

  2022cites this paper
• Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies

  2022cites this paper
• Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer’s Disease

  2022cites this paper
• Toxicities of amyloid-beta and tau protein are reciprocally enhanced in the Drosophila model

  2022cites this paper
• Fragment-Based and Structural Investigation for Discovery of JNK3 Inhibitors

  2022cites this paper
• Kinome-Wide Profiling Identifies Human WNK3 as a Target of Cajanin Stilbene Acid from Cajanus cajan (L.) Millsp.

  2022cites this paper
• Zinc in Regulating Protein Kinases and Phosphatases in Neurodegenerative Diseases

  2022cites this paper
• Rosmarinic acid suppresses tau phosphorylation and cognitive decline by downregulating the JNK signaling pathway

  2021cites this paper
• Defined Tau Phosphospecies Differentially Inhibit Fast Axonal Transport Through Activation of Two Independent Signaling Pathways

  2021cites this paper
• Dysregulated protein phosphorylation as main contributor of granulovacuolar degeneration at the first stages of NFT pathology.

  2021cites this paper
• Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies

  2021cites this paper
• Cell competition from development to neurodegeneration

  2021cites this paper
• Non-Canonical Roles of Tau and Their Contribution to Synaptic Dysfunction

  2021cites this paper
• Health Science Community Will Miss This Bright and Uniting Star: In Memory of Professor Gjumrakch Aliev, M.D, Ph.D.

  2021cites this paper
• A method for the expression of fibroblast growth factor 14 and assessment of its neuroprotective effect in an Alzheimer’s disease model

  2021cites this paper
• Novel Balance Mechanism Participates in Stem Cell Therapy to Alleviate Neuropathology and Cognitive Impairment in Animal Models with Alzheimer’s Disease

  2021cites this paper
• Repurposing Licensed Drugs for Use Against Alzheimer’s Disease

  2021cites this paper
• Restoration of the reduced CLSP activity alleviates memory impairment in Alzheimer disease

  2021influential citation
• Etanercept Reduces Neuron Injury and Neuroinflammation via Inactivating c-Jun N-terminal Kinase and Nuclear Factor-κB Pathways in Alzheimer's Disease: An In Vitro and In Vivo Investigation.

  2021cites this paper
• Mitochondrial Kinases and the Role of Mitochondrial Protein Phosphorylation in Health and Disease

  2021cites this paper
• Intracellular Sources of ROS/H2O2 in Health and Neurodegeneration: Spotlight on Endoplasmic Reticulum

  2021cites this paper
• Protective Effects of Nicotinamide Adenine Dinucleotide and Related Precursors in Alzheimer’s Disease: A Systematic Review of Preclinical Studies

  2021cites this paper
• Correction to: Acetaldehyde induces tau phosphorylation via activation of p38 MAPK/JNK and ROS production

  2021cites this paper
• Repressing c-Jun N-terminal kinase signaling mitigates retinal pigment epithelium degeneration in mice with failure to clear all-trans-retinal.

  2021cites this paper
• Acetaldehyde induces tau phosphorylation via activation of p38 MAPK/JNK and ROS production

  2021cites this paper
• A New Approach to Model Sporadic Alzheimer’s Disease by Intracerebroventricular Streptozotocin Injection in APP/PS1 Mice

  2021cites this paper
• Viscoelastic Response of Neurofilaments: An Atomistic Simulation Approach

  2021cites this paper
• Vanillic Acid, a Bioactive Phenolic Compound, Counteracts LPS-Induced Neurotoxicity by Regulating c-Jun N-Terminal Kinase in Mouse Brain

  2020cites this paper
• Small GTPases of the Ras and Rho Families Switch on/off Signaling Pathways in Neurodegenerative Diseases

  2020influential citation
• RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in Alzheimer’s disease

  2020cites this paper
• Understanding the Structure and Apo Dynamics of the Functionally Active JIP1 Fragment

  2020cites this paper
• Healthy Brain, Healthy Life: a review of diet and exercise interventions to promote brain health and reduce Alzheimer's disease risk.

  2020cites this paper
• Activation of JNK signaling promotes all-trans-retinal–induced photoreceptor apoptosis in mice

  2020cites this paper
• A transition to degeneration triggered by oxidative stress in degenerative disorders

  2020cites this paper
• C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes

  2020cites this paper
• Cognitive enhancing effect of diapocynin in D-galactose-ovariectomy-induced Alzheimer's-like disease in rats: Role of ERK, GSK-3β, and JNK signaling.

  2020cites this paper
• RAPGEF2 mediates oligomeric Aβ‐induced synaptic loss and cognitive dysfunction in the 3xTg‐AD mouse model of Alzheimer’s disease

  2020cites this paper
• Genetic Dissection of Alzheimer’s Disease Using Drosophila Models

  2020cites this paper
• Identification of dysregulated genes and pathways of different brain regions in Alzheimer’s disease

  2020cites this paper
• VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice

  2020cites this paper
• Beta-Amyloid Increases the Expression Levels of Tid1 Responsible for Neuronal Cell Death and Amyloid Beta Production

  2019cites this paper
• Biological Hallmarks of Cancer in Alzheimer’s Disease

  2019cites this paper
• Experimental Neurology

  2019cites this paper
• The olfactory bulb proteotype differs across frontotemporal dementia spectrum.

  2019cites this paper
• Prevention of Alzheimer's disease by treating mild cognitive impairment with combinations chosen from eight available drugs

  2019cites this paper
• Evidence for nucleolar dysfunction in Alzheimer’s disease

  2019cites this paper
• Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities

  2019cites this paper
• Acute exercise and brain BACE1 protein content: a time course study

  2019cites this paper
• Dose-dependent neuroprotective effect of the JNK inhibitor Brimapitide in 5xFAD transgenic mice.

  2019cites this paper
• Autophagy and Cell Death in Alzheimer’s, Parkinson’s and Prion Diseases

  2019cites this paper
• Inhibition of PDE5 attenuates streptozotocin-induced neuroinflammation and tau hyperphosphorylation in a streptozotocin-treated rat model.

  2019cites this paper
• Identification of an ERK Inhibitor as a Therapeutic Drug Against Tau Aggregation in a New Cell-Based Assay

  2019cites this paper
• Understanding the link between insulin resistance and Alzheimer's disease: Insights from animal models

  2019cites this paper
• Vanadyl acetylacetonate attenuates Aβ pathogenesis in APP/PS1 transgenic mice depending on the intervention stage

  2019cites this paper
• JIP1 Deficiency Protects Retinal Ganglion Cells From Apoptosis in a Rotenone-Induced Injury Model

  2019cites this paper
• Escitalopram Ameliorates Cognitive Impairment in D-Galactose-Injected Ovariectomized Rats: Modulation of JNK, GSK-3β, and ERK Signalling Pathways

  2019cites this paper
• Natural Antioxidant Anthocyanins—A Hidden Therapeutic Candidate in Metabolic Disorders with Major Focus in Neurodegeneration

  2019cites this paper
• Early-Onset Molecular Derangements in the Olfactory Bulb of Tg2576 Mice: Novel Insights Into the Stress-Responsive Olfactory Kinase Dynamics in Alzheimer’s Disease

  2019cites this paper
• Anti‐PrPC antibody rescues cognition and synapses in transgenic alzheimer mice

  2019influential citation
• Covalent Docking Identifies a Potent and Selective MKK7 Inhibitor.

  2019cites this paper
• Inhibition of fowl adenovirus serotype 4 replication in Leghorn male hepatoma cells by SP600125 via blocking JNK MAPK pathway.

  2019cites this paper
• Mitochondrial methionine sulfoxide reductase B2 links oxidative stress to Alzheimer's disease-like pathology.

  2019cites this paper
• Oxidative Stress in Alzheimer’s Disease: Molecular Hallmarks of Underlying Vulnerability

  2019cites this paper
• Tau, Diabetes and Insulin.

  2019cites this paper
• Effect of exercise on aging cardiac hypertrophy, role of oxidative pressure and some of the mitogen-activated protein kinases

  2018cites this paper
• Phosphorylation of microtubule-associated protein tau by mitogen-activated protein kinase in Alzheimer’s disease

  2018influential citation
• Brimapitide Reduced Neuronal Stress Markers and Cognitive Deficits in 5XFAD Transgenic Mice

  2018cites this paper
• USING THE FROG EPIDERMIS TO UNCOVER DESMOSOME FUNCTION AND REGULATION IN THE DEVELOPING EMBRYO

  2018cites this paper
• Mutual Relationship between Tau and Central Insulin Signalling: Consequences for AD and Tauopathies?

  2018cites this paper
• Accelerated brain aging towards transcriptional inversion in a zebrafish model of familial Alzheimer’s disease

  2018cites this paper
• Emerging role of the Jun N‐terminal kinase interactome in human health

  2018cites this paper
• Pigment Epithelium-Derived Factor Plays a Role in Alzheimer’s Disease by Negatively Regulating Aβ42

  2018cites this paper
• Phospho-proteomic analysis of primary human colon epithelial cells during the early Trypanosoma cruzi infection phase

  2018cites this paper
• Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review

  2018cites this paper
• A new etiologic model for Alzheimers Disease.

  2018cites this paper